Search for an orphan drug
Other search option(s)
Lintuzumab
- INN (International Nonproprietary Name) : -
- Code name : -
- Chemical name or description : -
- Type of product : Ingredient/substance
- Type of production : Biotechnology
- Orphan designation :
Orphan designation withdrawn/expired - Europe
- Diseases list
- Myelodysplastic syndrome
- Detailed information
Orphan designation withdrawn/expired - Europe
- Diseases list
- Acute myeloid leukemia
- Detailed information
Orphan designation - USA
- Diseases list
- Refractory anemia
- Aregenerative anemia
- Myelodysplastic syndrome
- Refractory anemia with excess blasts
- Unclassified myelodysplastic syndrome
- Acquired idiopathic sideroblastic anemia
- Refractory cytopenia with multilineage dysplasia
- Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
- Detailed information
Orphan designation - USA
- Diseases list
- Acute myeloid leukemia
- Acute erythroid leukemia
- Acute promyelocytic leukemia
- Acute myelomonocytic leukemia
- Acute megakaryoblastic leukemia
- Acute panmyelosis with myelofibrosis
- Acute myeloid leukaemia with myelodysplasia-related features
- Therapy related acute myeloid leukemia and myelodysplastic syndrome
- Detailed information
Additional information
Research on this medical product
Appraisal/reimbursement
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.